Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously-Reference-Cited by-同舟云学术

Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously

Published:2022-06-02 Issue:5 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Ahonen Anitta¹,Zhang Ying²,Marček Tomáš³^ORCID,Lumley Jessie⁴,Johnson David R.⁵,Guris Dalya⁶,Wilck Marissa B.⁶^ORCID

Affiliation:

1. Vaccine Research Center, University of Tampere, Tampere, Finland

2. Biostatistics, Merck & Co. Inc., Rahway, NJ, USA

3. MCM Vaccine B. V., Leiden, The Netherlands

4. Clinical Operations, Merck & Co., Inc., Rahway, NJ, USA

5. Global Medical and Vaxelis Business Unit, Sanofi Pasteur, Swiftwater, PA, USA

6. Clinical Research Vaccines, Merck & Co., Inc., Rahway, NJ, USA

Funder

funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2073747

Reference31 articles.

1. World Health Organization. Global hepatitis report, 2017. 2017 [accessed 2021 May 25]. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1.

2. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

3. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis

4. World Health Organization. Hepatitis B vaccines: WHO position paper – July 2017. 2017 [accessed 2021 May 10]. https://apps.who.int/iris/bitstream/handle/10665/255841/WER9227.pdf;jsessionid=6475C9E555C20312F6326A7E2B3ED1DD?sequence=1.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016);Human Vaccines & Immunotherapeutics;2024-02-08

2. Conventional vaccination methods: Inactivated and live attenuated vaccines;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024